Dermtech Stock Price, News & Analysis
Company Description
Dermtech (OTC Link: DMTKQ) is a publicly traded diagnostics & research company in the Healthcare sector. The company has a market capitalization of $3.5K.
DMTKQ stock has declined 100.0% over the past year. Shares last traded at $0.0000.
This page provides a comprehensive overview of DMTKQ stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Dermtech (DMTKQ) stock last traded at $0.0000. Over the past 12 months, the stock has lost 100.0%. At a market capitalization of $3.5K, DMTKQ is classified as a micro-cap stock with approximately 35.0M shares outstanding.
Latest News
Dermtech has 1 recent news article. Of the recent coverage, 0 articles coincided with positive price movement and 1 with negative movement. View all DMTKQ news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Dermtech (DMTKQ) currently stands at 205.9 thousand shares, representing 0.6% of the float. This relatively low short interest suggests limited bearish sentiment. With 267.1 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Dermtech (DMTKQ) currently stands at 267.1 days, up 1117.4% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has increased 458.1% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 8.7 to 267.1 days.
DMTKQ Company Profile & Sector Positioning
Dermtech (DMTKQ) operates in the Diagnostics & Research industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing DMTKQ often look at related companies in the same sector, including Interpace Biosciences Inc (IDXG), Stagezero Life (SZLSF), T2 Biosystems (TTOO), Angle Plc Surrey (ANPCF), and Immunovia Ab (IMMVF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate DMTKQ's relative position within its industry.